Biblio Discovery — Demo Discovery Service

4 results for "Mark Ross"

Showing 1–4 · 0.92 seconds · RSS

  1. Journal Article Full text

    Tebentafusp, A TCR/Anti-CD3 Bispecific Fusion Protein Targeting gp100, Potently Activated Antitumor Immune Responses in Patients with Metastatic Melanoma

    Mark Ross Middleton; Cheryl McAlpine; Victoria K. Woodcock et al.

    Clinical Cancer Research · 2020 · English · OpenAlex Scopus

    Abstract Purpose: Tebentafusp is a first-in-class bispecific fusion protein designed to target gp100 (a melanoma-associated antigen) through a high affinity T-cell receptor (TCR) binding domain and an anti-CD3 T-cell engaging domain, which redirects T cells to kill gp100-expressing tumor cells…

  2. Journal Article Full text

    European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 2. Treatment

    Alexander Stratigos; Claus Garbe; Clio Dessinioti et al.

    European Journal of Cancer · 2020 · English · OpenAlex Scopus

    In order to update recommendations on treatment, supportive care, education and follow-up of patients with invasive cutaneous squamous cell carcinoma (cSCC), a multidisciplinary panel of experts from the European Dermatology Forum, the European Association of Dermato-Oncology and the European…

  3. Journal Article Full text

    European interdisciplinary guideline on invasive squamous cell carcinoma of the skin: Part 1. epidemiology, diagnostics and prevention

    Alexander J. Stratigos; Claus Garbe; Clio Dessinioti et al.

    European Journal of Cancer · 2020 · English · OpenAlex Scopus

    Invasive cutaneous squamous cell carcinoma (cSCC) is one of the most common cancers in the white populations, accounting for 20% of all cutaneous malignancies. Factors implicated in cSCC etiopathogenesis include ultraviolet radiation exposure and chronic photoaging, age, male sex…